A comparative study on post-operative analgesic effect by intrathecal midazolam and neostigmine with control group

Rashmi Dubey; Roseline Ali; Rashim Vachhani; Nishant Baghel

doi:10.18203/2320-6012.ijrms20170626

Authors

Rashmi Dubey Department of Anesthesiology, CCM Medical College, Durg, Chhattisgarh, India
Roseline Ali Department of Anesthesiology, CCM Medical College, Durg, Chhattisgarh, India
Rashim Vachhani Department of Anesthesiology, CCM Medical College, Durg, Chhattisgarh, India
Nishant Baghel Department of Anesthesiology, CCM Medical College, Durg, Chhattisgarh, India

DOI:

https://doi.org/10.18203/2320-6012.ijrms20170626

Keywords:

Midazolam, Neostigmine, Pain, Post operation

Abstract

Background: Pain happens to be the most common suffering during postoperative period, which is not generally effectively treated. There is good evidence in literature that addition of midazolam to spinal bupivacaine improved postoperative analgesia when compared to spinal bupivacaine alone. Neostigmine represents a novel approach to providing analgesia. Recent studies showed that intrathecal administration of various doses of neostigmine produces analgesia without neurotoxicity. The present study was undertaken to evaluate analgesic effects of intrathecal Midazolam and neostigmine.

Methods: The present study was carried out in the department of anaesthesiology, CCM medical college, Durg Chhattisgarh, India during study period August 2015 to July 2016. The study comprised of 60 patients undergoing surgery of lower abdomen below umbilicus (T10) and lower limbs. Patients of age Group between 20-60 years of age of either sex of ASA group I and II were included in the study. Pre-anesthetic evaluation was done prior to surgery. The patients were randomly divided into 3 groups of 20 patients each. Data was compiled in MS excel and checked for its completeness and correctness, then it was analyzed.

Results: Mean age in Group I was 39.3+1.5 years. in Group II was 37.8±11.7 years, in Group III was 42.2±13.7 years. In group I maximum 14 patients (70%) had analgesia of less than 4 hours. Mean duration of analgesia was 3.73±0.87 hours. In group II maximum 18 patients (90%) had analgesia 4-8 hours. The mean duration of analgesia was 6.34±1.28 hours. In group III 10 patients (50%) had analgesia of 4-8 hours and 10 patients (50%) had analgesia of 8-12 hours. The mean duration was 8.35±1.36. The difference in VAS score in group in group I and group III is significant. There was no statistically significant change in systolic blood pressure, diastolic blood pressure, Pulse rate & respiratory rate attributable to intrathecal Midazolam and neostigmine.

Conclusions: Addition of preservative free midazolam to inteathecal bupivacaine prolongs duration of effective analgesia as compared to bupivacaine alone without any side effects. Addition of preservative free neostigmine to intrathecal bupivacaine prolongs duration of effective analgesia and sensory and motor block without any significant side effects.

Metrics

Metrics Loading ...

References

Abram SE, Winne RP. Intrathecal acetyl cholinesterase inhibitors produce analgesia that is synergistic with morphine and clonidine in rats. Anesth Analg. 1995;81:501-7.

D'Angelo R, Dean LS, Meister GC, Nelson KE. Neostigmine combined with bupivacaine, clonidine, and sufentanil for spinal lobor analgesia. Anesth. Analg. 2001;93:1560-4.

Serrao JM, Marks RL, Morley SJ, Goodchild CS. Intrathecal midazolam for the treatment of cronic mechanical low back pain: a control comparision with epidural steroid in a pilot study. Pain. 1992;48(1):5-12.

Goodchild CS, Noble J. The effects of intrathecal midazolam on sympathetic nervous system reflexes in man- a pilot study. Br. J. Clin. Pharmac. 1987;23:279-85.

Goodchild CS, Guo Z, Musgreave A, Gent JP. Antinociception by intrathecal midazolam involves endogenous neurotransmitters acting at spinal cord delta opioid receptors. Br. J. Anaesth. 1996;77:758-63.

Goodchild CS, Serrao JM. Intrathecal midazolam in the rat : evidence for spinally-mediated analgesia. Br.J. Anaesth. 1987;59:1563-70.

Seybold VS, Elde RP. Receptor authoradiography in thorasic spinal cord and correlation of neuro transmitter binding site with sympatho adrenal neuron. J Neuroscience. 1985;4:2533-42.

Tan PH, Kuo JH, Liu K, Hung CC, Tsai TC, Deng YC. Efficacy of intrathecal neostigmine for the relief of postinguinalherniorrhaphy pain; Pain. 2000;44(9):1056-9.

Tan PH, Chia YY, Lo Y, Liu K, Yang LC, Lee TH. Intrathecal bupivacaine with morphine or neostigmine for postoperative analgesia after total knee replacement surgery. Can.J. Anaesth. 2001;48(6):551-6.

Batra YK. Addition of intrathecal midazolam to bupivacaine produces better postoperative analgesia without prolonging recovery. Inj J. ClinPharmacolTher. 1999;37(10):519-23.

Gupta M, Shailaja S, Hegde KS. Comparison of intrathecal dexmedetomidine with buprenorphine as adjuvant to bupivacaine in spinal asnaesthesia. J Clinical and Diagnostic Research. 2014;2:114 -7.

Kim MH, Lee YM. Intrathecal midazolam increases the analgesic effects of spinal blockade with bupivacaine in patients undergoing haemorrhoidectomy. Br.J. Anaesth. 2001;86:77-9.

Lauretti GR, Hood DD, Eisenach JC, Pfeifer BL. A multi-center study of intrathecal neostigmine for analgesia following vaginal hysterectomy. Anaesthesiology. 1998;89(4):913-8.

Chung CJ, Kim JS, Park HS, Chin YJ. The efficacy of intrathecal neostigmine, intrathecal morphine, and their combination for post-cesarean section analgesia. Anesth. Analg. 1998;87:341-6.

Liu SS, Hodgson PS, Moore JM, Trautman WJ, Burkhead DL. Dose- response effects of spinal neostigmine added to bupivacaine spinal anaesthesia in volunteers. Anesthesiology. 1999;90(3):710-7.

Thomas W. Intrathecal buprenorphine for postoperative analgesia. Ind. J. Anaesth. 1997;41:188-9.